High Purity 99% Ciprofloxacin Hydrochloride CAS 86483 -48-9

China High Purity 99% Ciprofloxacin Hydrochloride CAS 86483-48-9, Find details about China Ciprofloxacin, Ciprofloxacin Hydrochloride from High Purity 99% Ciprofloxacin Hydrochloride CAS 86483-48-9

Model NO.
TGY022019061703
Product Name
Ciprofloxacin Hydrochloride
Specificcation
99%
Grade
Medicine Grade
Storage
Cool Dry Place
Shipping Time
Within 3-7 Working Days
Appearance
White Powder
CAS No.
86483-48-9
Trademark
TGY
Transport Package
Foil Bag, Box, Drum
Specification
99% min
Origin
China
HS Code
300440906
Model NO.
TGY022019061703
Product Name
Ciprofloxacin Hydrochloride
Specificcation
99%
Grade
Medicine Grade
Storage
Cool Dry Place
Shipping Time
Within 3-7 Working Days
Appearance
White Powder
CAS No.
86483-48-9
Trademark
TGY
Transport Package
Foil Bag, Box, Drum
Specification
99% min
Origin
China
HS Code
300440906


High Purity 99% Ciprofloxacin Hydrochloride CAS 86483-48-9
High Purity 99% Ciprofloxacin Hydrochloride CAS 86483-48-9
Product NameCiprofloxacin hydrochloride
SynonymsCiprofloxacin base HCL CAS 86483-48-9
CAS:Ciprofloxacin hydrochloride 86483-48-9
MF:-
MW:-
EINECS:-
Product Categories:Agrochemical Intermediates;Intermediates & Fine Chemicals;Dyestuff Intermediates;Flavor & Fragrance Intermediates;Gatiflo, Tequin and Zymar;Pharmaceutical intermediates

Moxifloxacin is a fourth-generation synthetic fluoroquinolone antibacterial agent developed by Bayer AG (initially called BAY 12-8039). It is marketed worldwide (as the hydrochloride) under the brand names Avelox, Avalox, and Avelon for oral treatment. In most countries, the drug is also available in parenteral form for intravenous infusion. Moxifloxacin is also sold in an ophthalmic solution (eye drops) under the brand names Vigamox, and Moxeza for the treatment of conjunctivitis (pink eye). Its antibacterial spectrum includes enteric Gram-() rods (Escherichia coli, Proteus species, Klebsiella species), Haemophilus influenzae, atypical bacteria (Mycoplasma, Chlamydia, Legionella), and Streptococcus pneumoniae, and anaerobic bacteria. It differs from earlier antibacterials of the fluoroquinolone class such as levofloxacin and ciprofloxacin in having greater activity against Gram-positive bacteria and anaerobes. Because of its potent activity against the common respiratory pathogen Streptococcus pneumoniae, it is considered a "respiratory quinolone."
 

High Purity 99% Ciprofloxacin Hydrochloride CAS 86483-48-9
In the United States, moxifloxacin is licensed for the treatment of acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis, community acquired pneumonia, complicated and uncomplicated skin and skin structure infections, and complicated intra-abdominal infections.[4] In the European Union, it is licensed for acute bacterial exacerbations of chronic bronchitis, non-severe community-acquired pneumonia, and acute bacterial sinusitis. 

 

High Purity 99% Ciprofloxacin Hydrochloride CAS 86483-48-9
High Purity 99% Ciprofloxacin Hydrochloride CAS 86483-48-9


High Purity 99% Ciprofloxacin Hydrochloride CAS 86483-48-9